menu ☰
menu ˟

Ranibizumab 0.5 mg effectively manages pigment epithelial detachment

21 Sep 2016
Monthly or as-needed 0.5-mg injections of ranibizumab were effective in treating pigment epithelial detachment associated with neovascular age-related macular degeneration, according to a post hoc analysis of the HARBOR study.Visual acuity improved r...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.